Tumor suppressive microRNA-218 inhibits cancer cell migration and invasion by targeting focal adhesion pathways in cervical squamous cell carcinoma.
about
Multistep model of cervical cancer: participation of miRNAs and coding genesTumor-suppressive microRNA-218 inhibits cancer cell migration and invasion via targeting of LASP1 in prostate cancer.RANK-mediated signaling network and cancer metastasis.Involvement of FAK-ERK2 signaling pathway in CKAP2-induced proliferation and motility in cervical carcinoma cell lines.A three miRNAs signature predicts survival in cervical cancer using bioinformatics analysis.MicroRNA-218 inhibits cell invasion and migration of pancreatic cancer via regulating ROBO1.A Comprehensive Review of Dysregulated miRNAs Involved in Cervical Cancer.Preliminary analysis of different microRNA expression levels in juvenile angiofibromas.The impact of pri-miR-218 rs11134527 on the risk and prognosis of patients with esophageal squamous cell carcinoma.The microRNA-218~Survivin axis regulates migration, invasion, and lymph node metastasis in cervical cancerMicroRNA-218 inhibits the proliferation and metastasis of esophageal squamous cell carcinoma cells by targeting BMI1.Quantitative assessment of pre-miR-218 rs11134527 polymorphism and cancer risk in Chinese population.Insulin-like growth factor binding protein-3 inhibits cell adhesion via suppression of integrin β4 expression.Epigenetic Repression of miR-218 Promotes Esophageal Carcinogenesis by Targeting ROBO1Inhibition of integrin β1 decreases the malignancy of ovarian cancer cells and potentiates anticancer therapy via the FAK/STAT1 signaling pathway.miR-1 suppresses the growth of esophageal squamous cell carcinoma in vivo and in vitro through the downregulation of MET, cyclin D1 and CDK4 expression.Regulation of viral oncogenesis by microRNAs.Profiling analysis of circulating microRNA expression in cervical cancerTumor-suppressive microRNA-29a inhibits cancer cell migration and invasion via targeting HSP47 in cervical squamous cell carcinoma.Decreased expression of miR-218 is associated with poor prognosis in patients with colorectal cancerA specific miRNA signature promotes radioresistance of human cervical cancer cellsMicroRNA-218 inhibits EMT, migration and invasion by targeting SFMBT1 and DCUN1D1 in cervical cancer.Predictive Value of MiR-219-1, MiR-938, MiR-34b/c, and MiR-218 Polymorphisms for Gastric Cancer Susceptibility and Prognosis.Regulation of the collagen cross-linking enzymes LOXL2 and PLOD2 by tumor-suppressive microRNA-26a/b in renal cell carcinoma.Propofol suppresses proliferation and invasion of glioma cells by upregulating microRNA-218 expression.MicroRNAs in gynecological cancers: Small molecules with big implications.Regulation of TPD52 by antitumor microRNA-218 suppresses cancer cell migration and invasion in lung squamous cell carcinoma.Identification of genes associated with histologic tumor grade of esophageal squamous cell carcinoma.The association between polymorphisms in microRNA genes and cervical cancer in a Chinese Han population.Genistein exerts potent antitumour effects alongside anaesthetic, propofol, by suppressing cell proliferation and nuclear factor-κB-mediated signalling and through upregulating microRNA-218 expression in an intracranial rat brain tumour model.LAMB3 mediates metastatic tumor behavior in papillary thyroid cancer by regulating c-MET/Akt signals.Adhesion, proliferation, and apoptosis in different molecular portraits of breast cancer treated with silver nanoparticles and its pathway-network analysis.The Role of miRNAs in Virus-Mediated Oncogenesis.The association of polymorphisms in miRNAs with nonsmall cell lung cancer in a Han Chinese population.Quantitative proteomic analysis of the miR-148a-associated mechanisms of metastasis in non-small cell lung cancer.
P2860
Q27001000-6A5CEE9F-88DE-4651-86E3-4FA8A5638536Q30009425-D0F8A46D-7CB5-429A-97A7-6D3969306E1BQ30371052-3B01DFA6-3200-4DAB-9640-EF69E8CC992AQ33704675-3B874D39-C778-4B4A-AAE3-93880BC70070Q33911718-1DF81638-CB59-4A79-B33A-3987654DB04EQ34036093-C999B3BC-E59B-46E6-81F6-740120BC27CEQ34049716-2668D163-F2C5-4067-80A6-169A5D53D52EQ34265640-E51101EB-75DC-499C-AAA3-4930C1479D14Q34371709-0047F74B-6685-4F52-AE04-264CE615531EQ35176023-74C1FEE1-4C93-44DD-B299-AAB06DF73F4CQ35827610-BCEB64CD-3D6A-445D-88F7-66476A3F68EEQ35907168-32151325-5C7E-4788-B58C-909542E177DBQ36020955-C0767354-699C-44CE-A8E7-228DDE02CB56Q36324811-0D82C6D4-CCE4-4D48-B8F3-5AFBAD88A577Q36592509-5F055A0B-07EC-4AA6-859F-78D21883C6D8Q36983766-57595C3C-2508-4139-9FF5-6ACEA4835D15Q36997713-7B54F0FE-DC70-4047-9C9E-36ED42613803Q37000943-52381AE7-7602-4255-8253-98B690C470B2Q37326148-0430137D-4D9E-498B-9560-D4AFEB15540CQ37349506-03D8D9CD-B3B2-4F6F-BE8E-850453FABC07Q37401645-7580351A-245D-4ED0-8C6C-E1DD80F4F34DQ37564508-DF9D2B3C-8751-44E8-93CE-4948557FBD8DQ37681002-01DB2269-0575-4531-8A43-5B9747A038E5Q38785857-6529E84A-1723-4768-9DDC-FEC523C3C350Q38858088-5998FD49-12E7-4823-9E67-F1E918557C81Q39333266-BC00C237-8274-4D88-AB4E-CCA0627149A1Q39384713-A6890D70-FA41-4BD1-90B6-8A64EC7114E9Q41627607-84145297-4397-4785-8D9B-A8B836CE7A23Q44977642-DFDBFC4A-DFD9-44A2-B1A0-A334563DF813Q47266864-FA6CE64A-1AED-4942-9897-0D0E128B2DDEQ50091069-8D872E44-03F2-40D7-8657-BCEA112DA2D4Q51744595-A468AD46-BF69-4116-B8F6-F8E3EA35DDE8Q53175931-FEDC2634-4A6B-48DF-A00D-58818D30C002Q55241989-CCE35E6E-ED4F-427A-A57F-A266E664D91AQ55263047-273397C1-F1FF-4E23-A4A1-3D7A67708F13
P2860
Tumor suppressive microRNA-218 inhibits cancer cell migration and invasion by targeting focal adhesion pathways in cervical squamous cell carcinoma.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Tumor suppressive microRNA-218 ...... vical squamous cell carcinoma.
@en
type
label
Tumor suppressive microRNA-218 ...... vical squamous cell carcinoma.
@en
prefLabel
Tumor suppressive microRNA-218 ...... vical squamous cell carcinoma.
@en
P2093
P2860
P356
P1476
Tumor suppressive microRNA-218 ...... vical squamous cell carcinoma.
@en
P2093
Hideki Enokida
Hirofumi Yoshino
Makio Shozu
Masayuki Nakagawa
Naohiko Seki
Nijiro Nohata
Noriko Yamamoto
Takashi Kinoshita
Toshihiko Itesako
P2860
P304
P356
10.3892/IJO.2013.1851
P577
2013-03-07T00:00:00Z